December 13, 2020
Whitehead Institute for Biomedical Research
This article is a preprint and has not been certified by peer review
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
document
COVID-19,FDA approvals,manufacturers,mRNA,reverse transcription,SARS-CoV-2 spike protein,vaccine composition,vaccine dynamics,vaccines